126,753 research outputs found
Niccolò Machiavelli „fejedelme”: Cesare Borgia
No full textSzakdolgozatom azt bizonyítja, hogy Niccolò Machiavelli "A fejedelem" című művét Cesare Borgiáról mintázta. Rövid bevezetés keretében kitérek mind a Borgia herceg és mind a szerző életpályájára. Majd források alapján ismertetem Machiavelli gondolkodásmódját, amit források alapján vizsgálva rávetítek a Borgia hercegre. Végezetül esik néhány szó a megítélésükről a történetírásban.BKTörténelemBSc/B
La Lucrezia Borgia di Maria Bellonci
No full textA dolgozat Lucrezia Borgia alakját járja körül irodalmi példák és Maria Bellonci meglátása alapján. Maria Bellonci Lucrezia Borgia című művének részletes elemzése olvasható benne. A mű elemzéséhez szükséges történelmi és kulturális áttekintés bemutatja a reneszánsz kori Itáliát. A főszereplő életének rövid bemutatása, valamint az írónő életének és pályájának leírása előzi meg még a konkrét elemzést. Az elemzés górcső alá veszi Maria Bellonci művét formailag, tartalmilag és nyelvileg, összehasonlítva más történészek, írók műveivel, valamint korabeli leírásokkal.BKRomanisztika - olasz szakirányBSc/B
Lucrèce Borgia
No full textLUCRÈCE BORGIA
Lucrèce Borgia ([1]r)
Title page ([1]r)
Person's index ([1]v)
Acte Premier. Affront sur affront ([2]r)
Première Partie ([2]r)
Deuxième Partie (24)
Acte Second. Le Couple (37)
Première Partie (37)
Deuxième Partie (62)
Acte Troisième. Ivres-Morts (68)
Lucrèce Borgia. Alphabetisches Wörterverzeichnis. (89)
Bibliothèue française (a)
Théâtre français. (b
Vertical transmission of hepatitis B virus: challenges and solutions
No full textIvan Gentile, Guglielmo BorgiaDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, ItalyAbstract: More than 240 million people worldwide are chronically infected with hepatitis B virus (HBV). Mother-to-child transmission remains the most important mechanism of infection in countries with a high prevalence of HBV. Universal screening of all pregnant women, at-birth prophylaxis with specific anti-HBV immune globulin, as well as HBV vaccination for newborns of infected mothers are effective in reducing the risk of vertical transmission. However, in cases of a high viral load and hepatitis B e antigen positivity, there is a residual risk of HBV transmission to the newborn despite prophylaxis. This review focuses on the above-indicated strategies and on the efficacy and safety of antiviral drugs administered during the third trimester of pregnancy.Keywords: immune globulin, prophylaxis, telbuvidine, tenofovir, vaccine, viral loa
TREATING CHRONIC HEPATITIS B: TODAY AND TOMORROW
No full textThree hundred and fifty million people worldwide are estimated to be chronically infected with hepatitis B virus. 15-40% of these subjects will develop cirrhosis, liver failure or hepatocellular carcinoma during their life. The treatment of chronic hepatitis B has improved dramatically over the last decade thanks to the advent of nucleoside/nucleotide analogues and the use of pegylated interferons. However, these agents have increased the complexity of the management of hepatitis B. Five drugs have been approved for chronic hepatitis B treatment: standard interferon-alpha 2b, pegylated interferon-alpha 2a, lamivudine, adefovir dipivoxil, and entecavir. A definite course of standard or pegylated interferon is administered to induce hepatitis B virus clearance. Unfortunately, these agents are not effective in all patients and are associated with not negligible side effects. Nucleoside or nucleotide analogues that inhibit hepatitis B virus polymerase induce on-treatment suppression of viral replication but patients tend to relapse after cessation of treatment. Consequently, these analogues, which are well tolerated, should be used for prolonged periods, even indefinitely. However, prolonged treatment is associated with a high rate of resistance. The following anti-hepatitis B virus drugs are currently undergoing clinical testing: telbivudine, emtricitabine, tenofovir disoproxil fumarate, clevudine and thymosin-+/-1. Here we will examine the mechanism of action, efficacy, safety, tolerability and emergence of resistance of agents used to treat chronic hepatitis B. We shall also examine the potential of drugs now being tested and of combination treatment
Going Beyond Counting First Authors in Author Co-citation Analysis
No full textThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Parution : Tlacuilolli : Die mexikanischen Bilderhandschriften. Stil und Inhalt. Mit einem Katalog der Codex-Borgia-Gruppe
No full textTlacuilolli : Die mexikanischen Bilderhandschriften Nowotny, Karl Anton (1908-1978). Auteur Résumé de l'éditeur Tlacuilolli is the Nahuatl word for writing or painting, so that by the title the author sets out to discuss Mexican manuscripts in terms of both their style and content. The manuscripts discussed are members of the so-called Codex Borgia Group -the Codices Borgia, Cospi, Laud, Fejervary-Mayer, Vaticanus B, and the Culte Rendu au Soleil (Bibliothèque Nationale, Pars, Ms Mex..
- …
